Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study
- 1 August 2004
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 94 (2) , 495-501
- https://doi.org/10.1016/j.ygyno.2004.04.008
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinomaCancer, 2001
- Prevalence of anemia in cancer patients undergoing radiation therapySeminars in Oncology, 2001
- Socioeconomic characteristics of patients with squamous cell carcinoma of the uterine cervix treated with radiotherapy in the 1992 to 1994 patterns of care studyInternational Journal of Radiation Oncology*Biology*Physics, 2000
- The importance of hemoglobin levels during radiotherapy for carcinoma of the cervixCancer, 1999
- Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical CarcinomaNew England Journal of Medicine, 1999
- Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical CancerNew England Journal of Medicine, 1999
- Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical CancerNew England Journal of Medicine, 1999
- Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: Results of a retrospective study of 386 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- The Phenomenon of Reoxygenation and Its Implications for Fractionated RadiotherapyRadiology, 1972